About Bluestar Genomics
Bluestar Genomics is reinventing non-invasive molecular diagnostic testing using next generation epigenomic technologies. Our tests provide novel insight and quantitation of human health and disease, with our focus on precision medicine applications improving both clinical and health system outcomes.
Our company was founded based on pioneering work in the Stanford laboratory of Stephen Quake, with advisors from Stanford, Oxford, U. Chicago, and UCSF. Our founding team has previously been innovators and leaders within many of the original nucleic acid, “liquid biopsy”, and single-cell genomics technology companies, such as Celera (acquired by Quest Diagnostics), Genomic Health (public), Verinata (acquired by Illumina), Quanticel (acquired by Celgene) and Immumetrix (acquired by CareDx). Bluestar is based in San Francisco and San Diego, California.
No open jobs at this moment